Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome

Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome

US Patent 8748627 · Granted Jun 10, 2014

Estimated economic value: $80,811,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sodium-hydrogen exchanger 3 inhibitor compounds2025
Method and apparatus to mitigate word line staircase etch stop layer thickness v2025
Methods of screening for condensate-associated specificity and uses thereof2025
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)2025
Smart battery swapping station compatible with multiple battery packs, control m2025
Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,32025
Relaxin analogs and methods of using the same2025
Kinetic sculpture and intelligent control system2025
Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-d2025
Method for interactive plot jumping, method for displaying interactive plot inte2025
Certificate revocation list updating method and related device2025
Infrared stealth cloth and infrared stealth clothes2025